Plaquenil®Lattice, do you yave a guesstimate on what sort of write down we might expect next quarter on Plaquenil? Rbc noted a further 40% pricing decrease today and this drug was a key contributor to last quarters $567 million write down. I suspect a signifigant further write down and guidance to be revised down again, but you probably have a better idea of how much.